My Blog List

Thursday, 9 November 2017

Radiopharmaceuticals in Nuclear Medicine Market Estimated to Grow Strongly by 2022

Description:

In this report, the Asia-Pacific Radiopharmaceuticals in Nuclear Medicine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for these regions, from 2012 to 2022 (forecast), including
China
Japan
South Korea
Taiwan
India
Southeast Asia
Australia
Asia-Pacific Radiopharmaceuticals in Nuclear Medicine market competition by top manufacturers/players, with Radiopharmaceuticals in Nuclear Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Bracco Imaging S.P.A.
Cambridge Isotope Laboratories, Inc.
Cardinal Health, Inc.
Covidien, Plc
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Isotec, Inc. (Sigma-Aldrich)
Lantheus Medical Imaging, Inc.
Nordion, Inc.
Ntp Radioisotopes (Pty), Ltd.
Siemens Healthcare (Subsidiary Of Siemens AG)
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries, Ltd., Inc.
Australian Nuclear Association And Technology Organization (ANSTO)
Board of Radiation And Isotope Technology (BRIT)
Institute of Atomic Energy Polatom Radioisotope Centre
Institute of Isotopes Co., Ltd.
Institute Of Radioelement (IRE)


On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Diagnostic Radiopharmaceuticals
Therapy Radiopharmaceuticals
Enriched Stable Isotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Radiopharmaceuticals in Nuclear Medicine for each application, includin
Diagnostic Application
Therapeutic Application
Research
Pharmaceutical
Other

Make an Enquiry Of report for Discount @ https://www.reporthive.com/enquiry.php?id=1137624&req_type=disc

Table of Content:

1 Radiopharmaceuticals in Nuclear Medicine Overview1.1 Product Overview and Scope of Radiopharmaceuticals in Nuclear Medicine
1.2 Classification of Radiopharmaceuticals in Nuclear Medicine by Product Category
1.2.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size (Sales) Comparison by Types (2012–2022)
1.2.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Diagnostic Radiopharmaceuticals
1.2.4 Therapy Radiopharmaceuticals
1.2.5 Enriched Stable Isotopes
1.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market by Application/End Users
1.3.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales (Volume) and Market Share Comparison by Applications (2012–2022)
1.3.2 Diagnostic Application
1.3.3 Therapeutic Application
1.3.4 Research
1.3.5 Pharmaceutical
1.3.6 Other
1.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market by Region
1.4.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Size (Value) Comparison by Region (2012–2022)
1.4.2 China Status and Prospect (2012–2022)
1.4.3 Japan Status and Prospect (2012–2022)
1.4.4 South Korea Status and Prospect (2012–2022)
1.4.5 Taiwan Status and Prospect (2012–2022)
1.4.6 India Status and Prospect (2012–2022)
1.4.7 Southeast Asia Status and Prospect (2012–2022)
1.4.8 Australia Status and Prospect (2012–2022)
1.5 Asia-Pacific Market Size (Value and Volume) of Radiopharmaceuticals in Nuclear Medicine (2012–2022)
1.5.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Growth Rate (2012–2022)
1.5.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue and Growth Rate (2012–2022)

2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Competition by Players/Suppliers, Region, Type and Application2.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Market Competition by Players/Suppliers
2.1.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales Volume and Market Share of Key Players/Suppliers (2012–2017)
2.1.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue and Share by Players/Suppliers (2012–2017)
2.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Type
2.2.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Type (2012–2017)
2.2.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Type (2012–2017)
2.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine (Volume) by Application
2.4 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine (Volume and Value) by Region
2.4.1 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Sales and Market Share by Region (2012–2017)
2.4.2 Asia-Pacific Radiopharmaceuticals in Nuclear Medicine Revenue and Market Share by Region (2012–2017)
Read Full Table of Contents

About Report Hive Research

We are a leading repository of market research reports and solutions catering to industries like Comm & Technology, Energy & Power, Food And Beverages, Automotive & Transportation, Healthcare & Life Science etc. This large collection of reports assists organizations in decision-making on aspects such as market entry strategies, market sizing, market share analysis, competitive analysis, product portfolio analysis and opportunity analysis among others. We also assist in determining the best suited and targeted report from our large repository of global reports, company-specific reports and country-level reports.

Contact Us

Mike Ross
Marketing Manager
mike.ross@reporthive.com
http://www.reporthive.com
Phone: +1 312–604–7084
Sainath Nagar, Vadgaon Sheri,
Pune, Maharashtra 411014,
India